Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
9472 patients were included in the study.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Subgroup analysis further showed that high GLR had better predictive value in liver cancer (HR:2.66, 95%CI:1.80-3.93), breast cancer (HR:2.13, 95%CI:1.10-4.13) and pancreatic cancer (HR:1.92, 95%CI:1.30-2.84). [CONCLUSIONS] GLR can be used as an effective prognostic marker in patients with solid tumors.
[BACKGROUND] Glucose-to-lymphocyte ratio (GLR) plays an important role in the prognosis of various tumors.
- 95% CI 1.34-1.63
- HR 1.48
- 연구 설계 meta-analysis
APA
Liu R, Shen Y, et al. (2024). Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors.. Frontiers in immunology, 15, 1454393. https://doi.org/10.3389/fimmu.2024.1454393
MLA
Liu R, et al.. "Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors.." Frontiers in immunology, vol. 15, 2024, pp. 1454393.
PMID
39712026 ↗
Abstract 한글 요약
[BACKGROUND] Glucose-to-lymphocyte ratio (GLR) plays an important role in the prognosis of various tumors. The aim of this study was to comprehensively evaluate the prognostic value of GLR in solid tumors through the meta-analysis.
[METHODS] A comprehensive search of eligible studies was performed by scrutinizing the Pubmed, Embase and Web of science databases until May 30, 2024. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to evaluate overall survival (OS), disease-free survival (DFS) and recurrence free survival (RFS).
[RESULTS] A total of 22 studies from 14 articles involving 9472 patients were included in the study. The pooled analysis showed that cancer patients with high GLR was significantly associated with unfavorable OS (HR:1.48,95% CI:1.34-1.63) and DFS/RFS (HR:2.20,95% CI:1.66-2.92). Subgroup analysis further showed that high GLR had better predictive value in liver cancer (HR:2.66, 95%CI:1.80-3.93), breast cancer (HR:2.13, 95%CI:1.10-4.13) and pancreatic cancer (HR:1.92, 95%CI:1.30-2.84).
[CONCLUSIONS] GLR can be used as an effective prognostic marker in patients with solid tumors.
[METHODS] A comprehensive search of eligible studies was performed by scrutinizing the Pubmed, Embase and Web of science databases until May 30, 2024. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to evaluate overall survival (OS), disease-free survival (DFS) and recurrence free survival (RFS).
[RESULTS] A total of 22 studies from 14 articles involving 9472 patients were included in the study. The pooled analysis showed that cancer patients with high GLR was significantly associated with unfavorable OS (HR:1.48,95% CI:1.34-1.63) and DFS/RFS (HR:2.20,95% CI:1.66-2.92). Subgroup analysis further showed that high GLR had better predictive value in liver cancer (HR:2.66, 95%CI:1.80-3.93), breast cancer (HR:2.13, 95%CI:1.10-4.13) and pancreatic cancer (HR:1.92, 95%CI:1.30-2.84).
[CONCLUSIONS] GLR can be used as an effective prognostic marker in patients with solid tumors.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy.
- Mechanistic insights into the roles of astragalosides and polysaccharides in gynecological and breast cancers (Review).
- Recent research progress in structural optimization and cancer treatment of novel selective FGFR inhibitors (2020-2025).
- Predicting cervical lymph node metastasis in papillary thyroid carcinoma using capsule disruption length measured by 3D-US.
- Ginkgolic acid targets HSPA8 to trigger ferroptosis in hepatocellular carcinoma chaperone-mediated autophagy-dependent GPX4 degradation.